Orshe

By Robert Lee Hotz

Here’s what’s making health news this morning:

Health Exchanges Have Boosters (WSJ): Officials in Rhode Island, California and Colorado expect to voluntarily implement a key part of the 2010 federal health-care overhaul — the establishment of insurance exchanges — even if it is wiped out by the Supreme Court.

Here’s what’s making health news today:

Health-Law Case Puts Roberts in Crucible (WSJ): The chief justice left himself room to uphold the health-care overhaul and stay in line with his comments made during this week’s oral arguments, though he seems more skeptical of the law than Justice Anthony Kennedy.

Here’s what’s making health news this morning:

Health Case Ripples Outward (WSJ): After three days of arguments over the constitutionality of the health-care overhaul, it’s impossible to predict how the Supreme Court will rule, but skepticism from some justices heightens the possibility it could be overturned in June. Also: Three Days of Hearings Yield Five Take-Aways.

Here’s what’s making health news this morning:

Health Law Slow to Win Favor (WSJ): Several of the law’s early pieces, designed to win public support, haven’t worked as well in the real world as on paper and have irked even some of the Americans they were designed to help.

The U.K. government’s controversial effort to overhaul the state-funded health system could come to a final vote as soon as this week amid criticism that plans will wreak administrative havoc and diminish patient care. WSJ’s Jeanne Whalen reports. Photo: Demotix

Read the original post: U.K. Vote to Overhaul National Health Service/a>

Here’s what’s making health news this morning:

Wholesalers Tied to Fake Avastin Had Earlier Scrape With Law (WSJ): Denmark’s National Board of Health says two directors of a company that acknowledged buying and selling a cargo of the fake cancer drug used to run a company that had its license to wholesale drugs revoked.

Here’s what’s making health news this morning:

J&J’s Drug Settlement for $1 Billion Is Rejected (WSJ): A proposed settlement for roughly $1 billion to resolve allegations that Johnson & Johnson promoted an antipsychotic drug for unapproved uses has been rejected by federal prosecutors in Washington, according to people familiar with the matter.

WSJ’s Ron Winslow has details of the success by some drug companies in developing treatments against advanced prostate cancer. Photo: Ramsay de Give for The Wall Street Journal

Read the original:  Drug Firms Making Strides Against Prostate Cancer/a>

From breakthrough drug treatments on the war on cancer to Japan’s food radiation scare, health news in 2011 abounded. Here’s a glimpse of some of the most important stories that hit WSJ headlines.

More here:  The Best Health Stories of 2011/a>

Some moviegoers catching the latest “Twilight” flick are reporting seizure-like symptoms. Epilepsy expert Dr. Carl Bazil discusses photosensitive epilepsy and weighs in on the “Breaking Dawn” scene triggering these symptoms. WSJ’s Christina Tsuei reports.

View original post here:  The Science Behind Reported ‘Twilight’ Seizures/a>